Abstract:Abstract Background Alzheimer’s disease (AD) is characterized by robust microgliosis and phenotypic changes that accompany disease pathogenesis. Accumulating evidence from genetic studies suggests the importance of phospholipase C γ 2 (PLCG2) in late-onset AD (LOAD) pathophysiology. However, the role of PLCG2 in AD is still poorly understood. Methods Using bulk RNA-Seq ( N =1249) data from the Accelerating Medicines Partnership-Alzheimer’s Disease Consortium (AMP-AD), we investigated whether PLCG2 expression increased in the brains of LOAD patients. We also evaluated the relationship between PLCG2 expression levels, amyloid plaque density, and expression levels of microglia specific markers ( AIF1 and TMEM119 ). Finally, we investigated the longitudinal changes of PLCG2 expression in the 5xFAD mouse model of AD. To further understand the role of PLCG2 in different signaling pathways, differential gene expression and co-expression network analyses were performed using bulk RNA-Seq and microglial single-cell RNA-Seq data. To substantiate the human analyses, we performed differential gene expression analysis on wild-type (WT) and inactivated Plcg2 mice and used immunostaining to determine if the differentially expressed genes/pathways were altered by microglial cell coverage or morphology. Results We observed significant upregulation of PLCG2 expression in three brain regions of LOAD patients and significant positive correlation of PLCG2 expression with amyloid plaque density. These findings in the human brain were validated in the 5xFAD amyloid mouse model, which showed disease progression-dependent increases in Plcg2 expression associated with amyloid pathology. Of note, increased Plcg2 expression levels in 5xFAD mice were abolished by reducing microglia. Furthermore, using bulk RNA-Seq data, we performed differential expression analysis by comparing cognitively normal older adults (CN) with 75th percentile (high) and 25th percentile (low) PLCG2 gene expression levels to identify pathways related to inflammation and the inflammatory response. The findings in the human brain were validated by differential expression analyses between WT and plcg2 inactivated mice. PLCG2 co-expression network analysis of microglial single-cell RNA-Seq data identified pathways related to the inflammatory response including regulation of I-kappaB/NF-kappa B signaling and response to lipopolysaccharide. Conclusions Our results provide further evidence that PLCG2 plays an important role in AD pathophysiology and may be a potential target for microglia-targeted AD therapies.

PLD3 in Alzheimer’s Disease

PLD3 in Alzheimer’s Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses

Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.

Common Variants In Pld3 And Correlation To Amyloid-Related Phenotypes In Alzheimer'S Disease

Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders

Phospholipase D3 regulates TFEB/TFE3 metabolism to maintain lysosomal homeostasis

Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson’s disease based on integrative analysis

Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism

Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort

Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph

The Role of PICALM in Alzheimer’s Disease

Association of Cd33 and Ms4a Cluster Variants with Alzheimer'S Disease in East Asian Populations

PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease

Genetic Variants Of Lipoprotein Lipase And Regulatory Factors Associated With Alzheimer'S Disease Risk

Association of Rare Variants in Neurodegenerative Genes with Familial Alzheimer's Disease.

Targeted sequencing on neurodegenerative genes identified novel causal and risk variants of familial Alzheimer's disease

Whole Exome Sequencing Analyses Identified Novel Genes for Alzheimer's Disease and Related Dementia

A Rare Variant in MLKL Confers Susceptibility to ApoE Ɛ4-Negative Alzheimer's Disease in Hong Kong Chinese Population.

P3‐120: MOLECULAR GENETIC ANALYSIS OF APP, PSEN1, AND PSEN2 GENES IN CHINESE PATIENTS WITH ALZHEIMER'S DISEASE

Phospholipase D1 Corrects Impaired Betaapp Trafficking and Neurite Outgrowth in Familial Alzheimer's Disease-Linked Presenilin-1 Mutant Neurons.

Association of DAPK1 Genetic Variations with Alzheimer's Disease in Han Chinese